Third Time’s A Charm? US FDA Once Again Proposes Mandatory Consumer Rx Info
Executive Summary
The US Food & Drug Administration is once again proposing a mandatory summary of key labeling information be dispensed with every prescription drug. Will the idea stay on the books this time?
You may also be interested in...
US FDA’s ‘Incremental Step’ On Rx Ads: A Long Time Coming
Final rule on the so-called ‘major statement’ in direct-to-consumer broadcast ads comes 15 years after the law it is implementing. A lot has changed in the advertising world since then – but FDA says the principles of ‘clear, conspicuous and neutral’ presentation of risk information still apply.
One-Page Patient Medication Information Document Moves Forward Under Proposed Rule
After decades of work, the US FDA released proposed requirements for a simplified version of the Medication Guide for all products. Electronic distribution in lieu of paper ‘upon a patient’s request’ would be allowed. Comments sought on the value of consumer testing of the documents.
US Patient Medical Information Rule: Will It Be Delayed Again?
FDA originally proposed mandatory patient labeling in 1980 only to have the rule withdrawn by the incoming Reagan Administration; thirty-five years later, US agency is finalizing a proposed rule on the same topic. Will history repeat itself?